| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/03/2012 | US8088384 Anti-NGF antibodies and methods using same |
| 01/03/2012 | US8088383 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
| 01/03/2012 | US8088380 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 01/03/2012 | US8088379 Modified T cell receptors and related materials and methods |
| 01/03/2012 | US8088377 Human monoclonal antibodies against CD30 |
| 01/03/2012 | US8088376 Fc variants with altered binding to FcRn |
| 01/03/2012 | US8088375 Anti-VEGF antibody |
| 01/03/2012 | CA2638884C Method for efficient purification of bionanocapsule |
| 01/03/2012 | CA2559345C Mutant endonuclease |
| 01/03/2012 | CA2498800C Sqs gene |
| 01/03/2012 | CA2480423C Truncated 24 kda basic fibroblast growth factor |
| 01/03/2012 | CA2466054C Apo-2 ligand/trail formulations |
| 01/03/2012 | CA2457636C Antigen binding domains |
| 01/03/2012 | CA2436049C A serpin in bifidobacteria |
| 01/03/2012 | CA2413258C Interferon-like protein zcyto21 |
| 01/03/2012 | CA2378574C Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-cd20 antibody |
| 01/03/2012 | CA2366433C Staphylococcus antigen and vaccine |
| 01/03/2012 | CA2348698C Variants of humanized anti-carcinoma monoclonal antibody cc49 |
| 01/03/2012 | CA2337490C Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules |
| 01/03/2012 | CA2266332C Antibodies against human parathyroid hormone related protein |
| 01/03/2012 | CA2260855C Polynucleotide vaccine formula in particular against bovine respiratory pathology |
| 01/03/2012 | CA2258348C Screening compounds for the ability to alter the production of amyloid-.beta. peptide (x-.gtoreq.41) |
| 01/03/2012 | CA2224468C P53 protein variants and therapeutical uses thereof |
| 01/03/2012 | CA2215483C Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same |
| 01/03/2012 | CA2178482C Thrombopoietin |
| 12/29/2011 | WO2011163478A2 Dual variable domain immunoglobulins and uses thereof |
| 12/29/2011 | WO2011162830A2 Glucagon-like peptide-1 glycopeptides |
| 12/29/2011 | WO2011160429A1 Anti-p185（her2/erbb2）humanized antibodies |
| 12/29/2011 | WO2011091350A3 Methods & compositions for improving protein production |
| 12/29/2011 | WO2011056644A3 Anti-glp-1r antibodies and their uses |
| 12/29/2011 | WO2001053458A9 Methods and reagents for performing antimicrobial compound screening |
| 12/29/2011 | US20110321197 Plants with Increased Yield (NUE) |
| 12/29/2011 | US20110321189 Polynucleotides and polypeptides involved in post-transcriptional gene silencing |
| 12/29/2011 | US20110321183 Methods for ligation and uses thereof |
| 12/29/2011 | US20110319593 Process for the production of biologically active hiv-1 tat protein |
| 12/29/2011 | US20110319590 Tumour Cell Lines and Uses Thereof |
| 12/29/2011 | US20110319327 Polypeptides Homologous to VEGF and BMP1 |
| 12/29/2011 | US20110319315 Muscle-building agent |
| 12/29/2011 | US20110318832 Human Telomerase Catalytic Subunit |
| 12/29/2011 | US20110318806 Site specific incorporation of keto amino acids into proteins |
| 12/29/2011 | US20110318782 Microbial Expression of Tobacco Osmotin for Biocidal and Medical Applications |
| 12/29/2011 | US20110318781 CYCLODIPEPTIDE SYNTHETASE AND ITS USE FOR SYNTHESIS OF CYCLO(Tyr-Xaa) CYCLODIPEPTIDES |
| 12/29/2011 | US20110318780 Enzymatic modification of glycopeptides |
| 12/29/2011 | US20110318779 Process for producing recombinant protein using novel fusion partner |
| 12/29/2011 | US20110318757 Recombinant anti-muc1 antibodies |
| 12/29/2011 | US20110318387 Immunization method using cancer cells |
| 12/29/2011 | US20110318371 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 12/29/2011 | US20110318369 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
| 12/29/2011 | US20110318362 Novel card proteins involved in cell death regulation |
| 12/29/2011 | US20110318357 Methods and compositions based on shiga toxin type 2 protein |
| 12/29/2011 | US20110318353 Humanized IL-25 Antibodies |
| 12/29/2011 | US20110318349 Dual variable domain immunoglobulins and uses thereof |
| 12/29/2011 | US20110318339 Anti-dll4 antibodies and uses thereof |
| 12/29/2011 | US20110318318 Anti-apoptotic fusion proteins |
| 12/29/2011 | US20110318301 Il-17a/f heterologous polypeptides and therapeutic uses thereof |
| 12/29/2011 | CA2803392A1 Dual variable domain immunoglobulins and uses thereof |
| 12/28/2011 | EP2400029A2 Methods for cyclic nucleotide determination |
| 12/28/2011 | EP2400021A2 ErbB3 based methods and compositions for treating neoplasms |
| 12/28/2011 | EP2399938A2 Peptide purification by means of hard metal ion affinity chromatography |
| 12/28/2011 | EP2399937A1 Anti-human alpha9 integrin antibody and use thereof |
| 12/28/2011 | EP2399935A2 An anti-CD137 antibody as an agent in the treatment of cancer and glycosylation variants thereof |
| 12/28/2011 | EP2399586A1 Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes |
| 12/28/2011 | EP2398889A1 Fermentation broth formulations |
| 12/28/2011 | EP2398822A1 Modification of factor viii |
| 12/28/2011 | EP2398498A2 Antibody molecules having specificity for human ox40 |
| 12/28/2011 | EP2398490A2 Modifications of cupredoxin derived peptides and methods of use thereof |
| 12/28/2011 | EP1967585B1 Method for gene amplification |
| 12/28/2011 | EP1916298B1 Methods for producing monoclonal antibodies |
| 12/28/2011 | EP1885867B1 Novel methods |
| 12/28/2011 | EP1308730B1 Method of detecting or assaying hbv |
| 12/28/2011 | CN1671737B 以羊毛硫抗生素途径输出并修饰(多)肽 In lantibiotic export pathway and modified (poly) peptide |
| 12/28/2011 | CN102300997A Toll样受体3拮抗剂 Toll-like receptor 3 antagonist |
| 12/28/2011 | CN102300878A 与溶基质蛋白酶1特异地发生反应的单克隆抗体 Occurrence and stromelysin-1 monoclonal antibody that reacts specifically |
| 12/28/2011 | CN102296101A 一种微胶囊包埋的紫菜降血压肽的制备方法 A microencapsulated seaweed preparation blood pressure lowering peptides |
| 12/28/2011 | CN102296100A 一种酪蛋白降血压肽的制备方法 Preparation of a drop in blood pressure casein peptide |
| 12/28/2011 | CN102296099A 从菜籽饼粕中提取蛋白和植酸的方法 Extracted from rapeseed meal protein and phytate |
| 12/28/2011 | CN102296098A 一种运用现代发酵技术生产高纯度云芝胞内糖肽的方法 A modern fermentation technology to produce high-purity versicolor intracellular glycopeptide Methods |
| 12/28/2011 | CN102295711A 从猪肺中提取肝素钠并联产多肽蛋白粉的工艺 Heparin extracted from lung and cogeneration technology polypeptide protein powder |
| 12/28/2011 | CN102295710A Method of comprehensive utilization of fresh bone with cartilage and simultaneous production of chondroitin sulfate and meat flavor |
| 12/28/2011 | CN102295681A Eb病毒潜伏膜蛋白2b细胞表位及应用 Eb virus latent membrane protein 2b cell epitopes and Applications |
| 12/28/2011 | CN101671394B 抗hAPE1蛋白的抗体及其制备方法与应用该抗体的试剂盒 HAPE1 anti-protein antibodies and methods of application of this antibody kit |
| 12/28/2011 | CN101629177B 重组细胞致死性扩张毒素CdtB、其表达载体及其制备方法 Recombinant cell expansion lethal toxin CdtB, expression vectors and its preparation method |
| 12/28/2011 | CN101580861B 具有抑制发酵乳后发酵的生物活性肽及其制备方法 Biologically active peptides and preparation of fermented milk fermented after suppression |
| 12/28/2011 | CN101481402B 一种分离纯化糖肽的方法 A method for separation and purification of glycopeptides |
| 12/28/2011 | CN101353633B Lactobacillus plantarum ZJ316、产生的抗菌肽及其制备与应用 Lactobacillus plantarum ZJ316, antimicrobial peptides produced its preparation and application |
| 12/28/2011 | CN101245350B 密码子优化的轮状病毒蛋白的编码核苷酸序列、其重组体及其应用 Codon optimized nucleotide sequence encoding a rotavirus protein, which recombinant Its Applications |
| 12/27/2011 | US8084597 Artificial entropic bristle domain sequences and their use in recombinant protein production |
| 12/27/2011 | US8084591 Blood coagulation factor; nucleotide encodes polypeptide; amino acid sequence differs from wild-type FVII or FVIIa; amino acid residue attachment group for non-polypeptide moiety has been introduced or removed; host cell is gammacarboxylating capable of in vivo glycosylation; coagulation disorders |
| 12/27/2011 | US8084585 Anti-ILT7 antibody |
| 12/27/2011 | US8084584 Methods for stabilizing proteins |
| 12/27/2011 | US8084582 Enhancing macrophage activation via co-administering CD20 specific and Fc gamma RIIIa immunoglobulins; targeted treatment of cell proliferative disorders |
| 12/27/2011 | US8084578 Monoclonal antibody against human scavenger receptor SRCL-P1 |
| 12/27/2011 | US8084424 Compositions and methods related to erythropoietin |
| 12/27/2011 | US8084413 Urocortin-III and uses thereof |
| 12/27/2011 | US8084252 Recombinant cell clones having increased stability and methods of making and using the same |
| 12/27/2011 | US8084251 Recombinant cell clones having increased stability and methods of making and using the same |
| 12/27/2011 | US8084240 Geobacillus stearothermophilus α-amylase (AmyS) variants with improved properties |
| 12/27/2011 | US8084238 Process for producing glycolic acid from formaldehyde and hydrogen cyanide |
| 12/27/2011 | US8084235 Purification process for bacterial cytolysin |
| 12/27/2011 | US8084233 Nucleic acids encoding anti-IL-12 antibody |